Postoperative Follow-Up for Patients with Non-Small Cell Lung Cancer

被引:17
|
作者
Nakamura, Ryota [2 ]
Kurishima, Koichi [3 ]
Kobayashi, Naohiro [2 ]
Ishikawa, Shigemi [2 ]
Goto, Yukinobu [2 ]
Sakai, Mitsuaki [2 ]
Onizuka, Masataka [2 ]
Ishikawa, Hiroichi [4 ]
Satoh, Hiroaki [1 ,3 ]
Hizawa, Nobuyuki [3 ]
Sato, Yukio [2 ]
机构
[1] Univ Tsukuba, Mito Med Ctr, Dept Internal Med, Mito, Ibaraki 3100015, Japan
[2] Univ Tsukuba, Div Cardiovasc Thorac Surg, Mito, Ibaraki 3100015, Japan
[3] Univ Tsukuba, Inst Clin Med, Mito, Ibaraki 3100015, Japan
[4] Tsukuba Med Ctr, Div Resp Med, Tsukuba, Ibaraki, Japan
来源
ONKOLOGIE | 2010年 / 33卷 / 1-2期
关键词
Non-small cell lung cancer; Surgery; Postoperative; Follow-up; Prognosis; SURVIVAL; QUALITY; CARE; SURVEILLANCE; COMORBIDITY; PHYSICIANS; RESECTION; SURGERY; INDEX; SCORE;
D O I
10.1159/000264623
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: It is unclear whether postoperative follow-up by thoracic surgeons or chest physicians for non-small cell lung cancer (NSCLC) alters survival. Patients and Methods: The charts of 1,398 NSCLC patients, diagnosed between 1980 and 2008, were reviewed. Prognostic factors contained therein were evaluated using univariate and multivariate analyses. Patients were divided into 2 groups according to the doctor in charge of their postoperative follow-up: the thoracic surgeon group and the chest physician group. The doctors in charge of following up the patients were also analyzed for prognostic significance. Results: In the univariate and multivariate analyses, age 65 years or younger, female sex, early pathological stage, Charlson Index score of 0-1, absence of adjuvant therapy, and follow-up by a chest physician were significantly favorable prognostic factors. Examined overall, NSCLC patients in the chest physician group had longer survival than those in the thoracic surgeon group. The difference in survival of patients with advanced disease was also statistically significant between these 2 groups. Conclusions: Our results indicate that early detection of asymptomatic disease by regular follow-up including chest computed tomography scan may improve the chance of treatment with curative intent and thus may increase survival, irrespective of the doctor in charge of follow-up.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [41] Impact of Postoperative Therapy on Survival Outcomes in Non-small Cell Lung Cancer Patients With Microscopic Residual Disease
    Watanabe, Hiroki
    Nakamura, Shota
    Imamura, Yoshito
    Okado, Shoji
    Nomata, Yuji
    Kawasumi, Yuta
    Kadomatsu, Yuka
    Ueno, Harushi
    Kato, Taketo
    Mizuno, Tetsuya
    Chen, Toyofumi fengshi
    ANTICANCER RESEARCH, 2025, 45 (03) : 1193 - 1204
  • [42] Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer
    Sakamoto, Jin
    Sonobe, Makoto
    Kobayashi, Masashi
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Nakajima, Daisuke
    Yamada, Tetsu
    Nakayama, Ei
    Takahashi, Tsuyoshi
    Sato, Toshihiko
    Chen, Fengshi
    Bando, Toru
    Date, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 50 - 56
  • [43] Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients
    Hiroaki Toba
    Naoya Kawakita
    Mika Takashima
    Daisuke Matsumoto
    Hiromitsu Takizawa
    Hideki Otsuka
    Akira Tangoku
    General Thoracic and Cardiovascular Surgery, 2021, 69 : 311 - 317
  • [44] Pathological response and prognosis of stage III non-small cell lung cancer patients treated with induction chemoradiation
    Isobe, Kazutoshi
    Hata, Yoshinobu
    Sakaguchi, Shinji
    Sato, Fumitomo
    Takahashi, Shoji
    Sato, Keita
    Sano, Go
    Sugino, Keishi
    Sakamoto, Susumu
    Takai, Yujiro
    Mitsuda, Aki
    Terahara, Atsuro
    Shibuya, Kazutoshi
    Takagi, Keigo
    Homma, Sakae
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 (03) : 260 - 266
  • [45] Impact of Interstitial Lung Disease on Survival for Patients with Non-small Cell Lung Cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Ohara, Gen
    Hizawa, Nobuyuki
    ANTICANCER RESEARCH, 2009, 29 (07) : 2671 - 2674
  • [46] Clinical impact of preoperative sarcopenia and immunonutritional impairment on postoperative outcomes in non-small cell lung cancer surgery
    Uchibori, Atsuki
    Okada, Satoru
    Shimomura, Masanori
    Furuya, Tatsuo
    Nakazono, Chiaki
    Nishimura, Tomoki
    Inoue, Masayoshi
    LUNG CANCER, 2024, 198
  • [47] Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study
    Jing, Wang
    Liu, Yufei
    Zhu, Hui
    Welsh, James
    Gandhi, Saumil
    Jeter, Melenda
    Nguyen, Quynh
    Chen, Aileen B.
    O'Reilly, Michael
    Liao, Zhongxing
    Chang, Joe Y.
    Lee, Percy
    Lin, Steven H.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 28 : 54 - 61
  • [48] Patterns of follow-up care after curative radiotherapy ± chemotherapy for stage I-III non-small cell lung cancer
    Mohan, Sharanya
    Beydoun, Nadine
    Nasser, Elias
    Nguyen, Andrew
    Shafiq, Jesmin
    Vinod, Shalini
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (03) : 172 - 180
  • [49] Spatial metabolomics for evaluating response to neoadjuvant therapy in non-small cell lung cancer patients
    Shen, Jian
    Sun, Na
    Zens, Philipp
    Kunzke, Thomas
    Buck, Achim
    Prade, Verena M.
    Wang, Jun
    Wang, Qian
    Hu, Ronggui
    Feuchtinger, Annette
    Berezowska, Sabina
    Walch, Axel
    CANCER COMMUNICATIONS, 2022, 42 (06) : 517 - 535
  • [50] Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study
    Ilonen, Ilkka K.
    Rasanen, Jari V.
    Knuuttila, Aija
    Sihvo, Eero I.
    Sintonen, Harri
    Sovijarvi, Anssi R. A.
    Salo, Jarmo A.
    LUNG CANCER, 2010, 70 (03) : 347 - 351